-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Bc7cOEX497N4dfB8mncW4SBzIFi4WgJSUs+FXAZ569oonvDLskM8JmtgeFV4UMFu YpDz10k71ZMBqhyWgiaNOg== 0001047469-04-012392.txt : 20040416 0001047469-04-012392.hdr.sgml : 20040416 20040416172958 ACCESSION NUMBER: 0001047469-04-012392 CONFORMED SUBMISSION TYPE: 8-A12G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040416 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON BIOMEDICA INC CENTRAL INDEX KEY: 0000830656 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042652826 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-A12G/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-21615 FILM NUMBER: 04739119 BUSINESS ADDRESS: STREET 1: 375 WEST STREET CITY: WEST BRIDGEWATER STATE: MA ZIP: 02379 BUSINESS PHONE: 5085801900 MAIL ADDRESS: STREET 1: 375 WEST ST CITY: WEST BRIDGEWATER STATE: MA ZIP: 02379 8-A12G/A 1 a2133932z8-a12ga.htm FORM 8-A/A
QuickLinks -- Click here to rapidly navigate through this document

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-A/A
Amendment No. 1
To Registration Statement on Form 8-A, dated March 12, 2003

For Registration of Certain Classes of Securities
Pursuant to Section 12(b) or 12(g) of the
Securities Exchange Act of 1934

BOSTON BIOMEDICA, INC.
(Exact Name of Registrant as Specified in its Charter)

Massachusetts
(State of Incorporation or Organization)		   04-2652826
(I.R.S. Employer Identification No.)


375 West Street, West Bridgewater, MA 02379
(Address of principal executive offices) (Zip Code)

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. o

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. ý

Securities Act registration statement file number to which this form relates:             (if applicable)

Securities to be registered pursuant to Section 12(b) of the Act:

Title of Each Class
To Be So Registered
   Name of Each Exchange on Which
Each Class Is To Be Registered
None   None

Securities to be registered pursuant to Section 12(g) of the Act:

Preferred Share Purchase Rights


(Title of Class)


Item 1. Description of Registrant's Securities to be Registered.

        Reference is made to the description of the Preferred Share Purchase Rights contained in the Registrant's Form 8-A filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, on March 12, 2003, which is incorporated herein by reference.


Item 2. Exhibits.

4.01   Rights Agreement between the Registrant and Computershare Trust Company, as Rights Agent, dated as of February 27, 2003 (Filed as Exhibit 4 to the Registrant's Current Report on Form 8-K filed with the Commission on March 12, 2003).*

4.02
 
Amendment No. 1 to Rights Agreement, dated as of April 16, 2004 (Filed as Exhibit 4 to the Registrant's Form 8-K filed with the Commission on April 16, 2004).*
*
Not filed herewith. In accordance with Rule 12b-32 promulgated pursuant to the Securities Exchange Act of 1934, as amended, reference is made to the documents previously filed with the Commission, which are incorporated by reference herein.


SIGNATURE

        Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: April 16, 2004   BOSTON BIOMEDICA, INC.

 
 
By:
/s/  KEVIN W. QUINLAN      
Kevin W. Quinlan
President, Chief Operating Officer and Treasurer


QuickLinks

SIGNATURE
 -----END PRIVACY-ENHANCED MESSAGE-----